Group 1 - The core viewpoint of the article highlights that Maike Biological has a high rolling price-to-earnings (PE) ratio of 238.79, significantly above the industry average of 49.84 and median of 36.59, indicating a potentially overvalued stock in the medical device sector [1][2] - As of the first quarter of 2025, four institutions hold shares in Maike Biological, with a total of 25.43 million shares valued at 331 million yuan [1] - The company specializes in the research, production, sales, and service of in vitro diagnostic products, being one of the first domestic IVD companies to establish a traceability system for measurement values [1] Group 2 - The latest financial results for the first quarter of 2025 show that Maike Biological achieved a revenue of 510 million yuan, representing a year-on-year decrease of 17.22%, and a net profit of 23.98 million yuan, down 80.09% from the previous year, with a gross profit margin of 56.76% [1] - In terms of market capitalization, Maike Biological is valued at 7.246 billion yuan, ranking 117th in the industry based on PE ratio [2] - The average PE ratio for the medical device industry is 49.84, with a median of 36.59, indicating that Maike Biological's valuation is significantly higher than its peers [2]

迈克生物股份有限公司主要从事体外诊断产品研发、生产、销售和服务。公司主营产品包括自产和代理 诊断试剂及诊断仪器。公司产品具备国际一流的品质，是国内IVD企业最早建立量值溯源系统的公司， 也是国际医学量值溯源体系国际检验医学溯源联合委员会(JCTLM)中首家中国企业代表。 最新一期业绩显示，2025年一季报，公司实现营业收入5.10亿元，同比-17.22%；净利润2397.96万元， 同比-80.09%，销售毛利率56.76%。 5月6日，迈克生物今日收盘11.54元，上涨1.50%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到232.94倍，总市值70.68亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均48.90倍，行业中值36.41倍，迈克生物排 名第117位。 截至2025年一季报，共有4家机构持仓迈克生物，其中其他2家、QFII1家、基金1家，合计持股数 2542.85万股，持股市值3.31亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)117迈克生物232.9455.741.1170.68亿行业平均 48.9047.004.53103.78亿行业中值36. ...

最新一期业绩显示，2024年三季报，公司实现营业收入19.48亿元，同比-7.92%；净利润2.81亿元，同比 4.72%，销售毛利率57.19%。 迈克生物股份有限公司主要从事体外诊断产品研发、生产、销售和服务。公司主营产品包括自产和代理 诊断试剂及诊断仪器。公司产品具备国际一流的品质,是国内IVD企业最早建立量值溯源系统的公司， 也是国际医学量值溯源体系国际检验医学溯源联合委员会（JCTLM)中首家中国企业代表。 序号股票简称PE(TTM)PE(静)市净率总市值(元)52迈克生物22.2923.201.1172.52亿行业平均 45.9448.384.71101.41亿行业中值29.6428.792.3545.52亿1天益医疗-2672.56-2672.561.6719.88亿2硕世生 物-1835.15-1835.151.1537.91亿3诺唯赞-549.11-549.112.5299.35亿4博晖创新-335.30-206.443.6951.46亿5康 泰医学-262.5830.812.6851.07亿6华大基因-197.28215.792.04200.47亿7奥精医疗-108.26-108.261. ...